Papers using
Sp3
antibodies
Papers on
Sp3
Analysis of differentially expressed genes based on microarray data of glioma.Zhou et al., Nanjing, China. In Int J Clin Exp Med, 2014
In addition, the transcription factor analysis showed these DEGs were regulated by the binding sites of transcription factors GLI2, SP1, SMAD7, SMAD3, RELA, STAT5B, CTNNB1, STAT5A, TFAP2A and SP3.
Pirfenidone: an update on clinical trial data and insights from everyday practice.Kreuter, Heidelberg, Germany. In Eur Respir Rev, 2014
It was approved for the treatment of adults with mild-to-moderate idiopathic pulmonary fibrosis in the European Union based on the results of two pivotal phase III, double-blind, randomised, placebo-controlled clinical trials (CAPACITY) demonstrating efficacy and safety, and supported by two Japanese clinical trials (SP2 and SP3).
Regulatory mechanisms of the HB-EGF autocrine loop in inflammation, homeostasis, development and cancer.Miyamoto et al., Fukuoka, Japan. In Anticancer Res, 2012
Enhancement of HB-EGF expression is directly or indirectly regulated by transcriptional factors, including activator protein-1 (AP-1), specificity protein (SP)1, SP3, nuclear factor kappa B (NF-κB), hypoxia inducible factor 1, alpha subunit (HIF-1α, myogenic differentiation 1 (MyoD), Wilms tumor 1 (WT-1) and snail homolog 1 (Snail), and also by microRNAs.